Executive readout · one minute
Call research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
ONC
$365.94
+0.18%
ONC
· BeOne Medicines Ltd.
$365.94
+0.67 (+0.18%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$40.82B
Shares
113.12M
Volume · Sep 30
328.88K
Avg daily vol (3M)
388.06K
All earnings calls
Earnings call · FY2026 Q2
BeOne Medicines Ltd. (ONC) Q2 2026 Earnings Call
Research coverage
4 live sources
Open each available source without leaving this research workspace.
Revenue
$1.71B
+29.6% YoY
Diluted EPS
$0.16
+166.7% YoY
Gross margin
89.8%
+2.3 pp YoY
Net income
$237.01M
+151.3% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
Company presentation
Slides
12 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 26, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Aug 5, 2026 · complete as-filed document